Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Deferred Taxes (2010 - 2018)

Cryo Cell International (CCEL) reported Deferred Taxes of -$738772.0 for Q4 2018, up 12.91% year-over-year from -$654282.4 in Q4 2017, and down 887.39% on a QoQ basis from $93826.0 in Q3 2018.

Cryo Cell International (CCEL) has 6 years of Deferred Taxes data on file, last reported at -$738772.0 in Q4 2018.

  • Quarterly Deferred Taxes rose 12.91% year-over-year to -$738772.0 in Q4 2018, while the trailing twelve-month figure through Nov 2018 was $2.4 million (up 238.64% YoY) and the FY2025 annual result came in at -$2.8 million, down 811.39% from the prior year.
  • Deferred Taxes slipped to -$738772.0 in Q4 2018 per CCEL's latest filing, from $93826.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $3.0 million in Q1 2018 and bottomed at -$1.1 million in Q4 2016.
  • The 4-year median for Deferred Taxes is -$8589.0 (2017), against an average of $82862.0.
  • The widest annual swing landed in 2016, when Deferred Taxes tumbled 646.29%; it then surged 1296.84% in 2018.
  • Tracing CCEL's Deferred Taxes over 4 years: stood at $195834.0 in 2015, then plunged by 646.29% to -$1.1 million in 2016, then climbed by 20.71% to -$848318.0 in 2017, then rose by 12.91% to -$738772.0 in 2018.
  • Per Business Quant, the three latest CCEL Deferred Taxes figures stand at -$738772.0 (Q4 2018), $93826.0 (Q3 2018), and -$23895.0 (Q2 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 435.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -40.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 54.80 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 8.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -104.77 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 3.89 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -4.74 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -12.46 Mn
10 Cryo Cell International 27.15 Mn 24.25 Mn 6.03 Mn -

Historic Data

Download Data 🔒
DateValue
Nov 30, 2018 -738,772.00
Aug 31, 2018 93,826.00
May 31, 2018 -23,895.00
Feb 28, 2018 3.05 Mn
Nov 30, 2017 -848,318.00
Aug 31, 2017 6,717.00
Nov 30, 2016 -1.07 Mn
Nov 30, 2015 195,834.00
Nov 30, 2012 -157,219.00
Nov 30, 2010 69,322.00